Mitochondrial heteroplasmy improves risk prediction for myeloid neoplasms
Abstract Clonal hematopoiesis of indeterminate potential is the primary pathogenic risk factor for myeloid neoplasms, while heteroplasmy (mutations in a subset of cellular mitochondrial DNA) is another marker of clonal expansion associated with hematological malignancies. We explore how these two ma...
Saved in:
| Main Authors: | Yun Soo Hong, Sergiu Pasca, Wen Shi, Daniela Puiu, Nicole J. Lake, Monkol Lek, Meng Ru, Megan L. Grove, Anna Prizment, Corinne E. Joshu, Elizabeth A. Platz, Eliseo Guallar, Dan E. Arking, Lukasz P. Gondek |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2024-11-01
|
| Series: | Nature Communications |
| Online Access: | https://doi.org/10.1038/s41467-024-54443-3 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The quality and detection limits of mitochondrial heteroplasmy by long read nanopore sequencing
by: Barbara Slapnik, et al.
Published: (2024-11-01) -
Age-Related and Heteroplasmy-Related Variation in Human mtDNA Copy Number.
by: Manja Wachsmuth, et al.
Published: (2016-03-01) -
HETEROPLASMY-ASSOCIATED MITOCHONDRIAL DNA VARIANTS IN HUMAN BLOOD AND SKELETAL MUSCLE SAMPLES
by: Çağrı Güleç, et al.
Published: (2024-01-01) -
EPIDEMIOLOGY OF THERAPY-RELATED MYELOID NEOPLASMS IN THE NORDIC COUNTRIES
by: Kjeld Schmiegelow
Published: (2011-01-01) -
EPIDEMIOLOGY OF THERAPY-RELATED MYELOID NEOPLASMS IN THE NORDIC COUNTRIES
by: Kjeld Schmiegelow
Published: (2011-05-01)